Whitepaper/App Note

Whitepaper: Sensitive and flexible bacterial endotoxin testing with the EndoZyme® II Recombinant Factor C Assay using the Synergy™ HTX Microplate Reader

Posted: 13 December 2017 | | No comments yet

This article covers how the EndoZyme II assay is established, optimised and validated using the SynergyTM HTX Multi-Mode Microplate Reader with Gen5TM software…

EndoZyme® II is a bacterial endotoxin test for pharmaceuticals and medical devices as well as their in-process intermediates and raw materials. The assay relies on recombinant horseshoe crab Factor C (rFC), an exact synthetic copy of the endotoxin-sensitive enzyme naturally harboured by the blood of horseshoe crabs. Compared with methods sourced from these animals, rFC methods offer better specificity, flexibility, lot-to-lot consistency and, importantly: a sustainable and secure source.

This whitepaper is restricted - login or subscribe free to access

european pharmaceutical review magazine cover issue 2 2018Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Related content from this organisation

    Send this to a friend